Poultry Pharmaceuticals Market Size is valued at USD 6.72 Bn in 2022 and is predicted to reach USD 14.03 Bn by the year 2031 at an 8.68% CAGR during the forecast period for 2023-2031.
Poultry pharmaceuticals, referred to as poultry medications or veterinary drugs for poultry, encompass a range of pharmaceutical treatments specifically formulated to promote the health and overall welfare of poultry, including chickens, turkeys, ducks, and other domestic fowl. The poultry pharmaceutical sector has a significant impact on the healthcare system worldwide, from patients in need of medication to doctors interested in cutting-edge research. Keeping up with the latest developments in the market is essential if you want to succeed. Poultry pharmaceutical businesses increase the birds' immune systems so that they manufacture antibodies much more quickly to fight off invaders, hence halting the spread of a particular disease. Vaccines for chickens are critical for preventing illness outbreaks. Vaccine development efforts have primarily focused on fighting viral infections in poultry. Vaccines can be administered by the nares, oral cavity, eyes, skin, or musculature.
In addition, the number of medicines that have been licensed for use and the necessity for poultry vaccinations to cure diseases are expected to propel market expansion over the forecast period. A poultry farm's profitability and productivity are directly correlated to the quality of the birds' health care.
However, the use of poultry vaccines has a wide range of consequences: mild discharge from the eyes and nose, local swelling and discomfort at the vaccination site, a loss of appetite and energy, sneezing, a mild temperature, and a minor cough are all symptoms that may occur locally. Thus, this aspect challenges the expansion of the market. The spread of COVID-19 has considerably impacted the demand for poultry healthcare.
Animal items like meat, milk, and eggs had trouble making it to needs in the beginning because of the disruption in the supply chain caused by the international embargo. As the number of reported instances of COVID-19 has decreased, trade and agricultural output have increased, leading to better care and nutrition for the hens, which has raised the need for poultry healthcare, propelling the market forward throughout the projection period. The increasing prevalence of zoonotic infections, together with the increased demand for poultry-derived food products, are all factors that are driving market expansion.
The poultry pharmaceutical market is segmented based on product type, feed additives and animal type. As per the product type, the market is segmented into drugs, verotoxin, other drug products, vaccines, INNOVAX, NOBILIS, poulvac, and other vaccine products. By feed additives the market is segmented into VIGOSINE, Amnovit, and other feed additives. By animal type, the market is segmented into chicken, turkey, duck, goose, and others.
The drugs category is expected to hold a major global market share in 2022. The rising incidence of Zoonotic diseases is driving growth in the drug segment of the poultry pharmaceuticals market over the forecast period. To protect the health and wellbeing of the birds, to prevent the emergence of antibiotic resistance, and to address other potential problems, it is crucial for poultry farmers and veterinarians to administer these medications sensibly and in line with the law.
Chicken is projected to grow rapidly in the global poultry pharmaceuticals market. Due to this, chicken is predicted to be the most lucrative sub-segment of the global poultry pharmaceuticals market over the forecast period. Growth in this sector is anticipated during the projection period to be driven by the increased government measures to preventative vaccines in countries like the US, Germany, the UK, China, and India.
The North American poultry pharmaceuticals Market is expected to record the maximum market share in revenue in the near future. It can be attributed to increased demand in the global poultry pharmaceuticals market, which may be traced back to the rising incidence of Zoonotic and infectious diseases. In addition, Asia Pacific is estimated to grow rapidly because more people are learning about the importance of preventing diseases like polio and rabies. The government is providing free inoculation camps to protect more people from contagious diseases.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 6.72 Bn |
|
Revenue Forecast In 2031 |
USD 14.03 Bn |
|
Growth Rate CAGR |
CAGR of 8.68% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Animal Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
Aervoe Industries Inc., Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, Avivagen Inc., Hester Biosciences Limited, Venkys India, Calier, KM Biologics, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Poultry Pharmaceuticals Market Snapshot
Chapter 4. Global Poultry Pharmaceuticals Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Drugs
5.2.1.1. VETRIMOXIN
5.2.1.2. Other Drug Products
5.2.2. Vaccines
5.2.2.1. INNOVAX
5.2.2.2. NOBILIS
5.2.2.3. Poulvac
5.2.2.4. Other Vaccine Products
5.2.3. Feed Additives
5.2.3.1. VIGOSINE
5.2.3.2. Amnovit
5.2.3.3. Other Feed Additives
Chapter 6. Market Segmentation 2: By Animal Type Estimates & Trend Analysis
6.1. By Animal Type & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Animal Type:
6.2.1. Chicken
6.2.2. Turkey
6.2.3. Duck
6.2.4. Goose
6.2.5. Others
7.1. Global Poultry Pharmaceuticals Market , Regional Snapshot 2023 & 2031
7.2. North America
Chapter 7. Poultry Pharmaceuticals Market Segmentation 3: Regional Estimates & Trend Analysis
7.2.1. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.2.3. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
7.3. Europe
7.3.1. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.3.3. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
7.4. Asia Pacific
7.4.1. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Hong Kong
7.4.1.7. Southeast Asia
7.4.1.8. Rest of Asia Pacific
7.4.2. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.4.3. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts By Product type, 2024-2031
7.5. Latin America
7.5.1. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.5.3. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
7.6. Middle East & Africa
7.6.1. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.6.1.1. GCC Countries
7.6.1.2. Israel
7.6.1.3. South Africa
7.6.1.4. Rest of Middle East and Africa
7.6.2. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.6.3. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Aervoe Industries Inc.
8.2.1.1. Business Overview
8.2.1.2. Key Product/Service Overview
8.2.1.3. Financial Performance
8.2.1.4. Geographical Presence
8.2.1.5. Recent Developments with Business Strategy
8.2.2. Bayer AG,
8.2.3. Bimeda
8.2.4. Ceva Sante Animale
8.2.5. Elanco Animal Health (Eli Lilly and Company)
8.2.6. Merck Animal Health
8.2.7. Merial Animal Health (Sanofi)
8.2.8. Virbac
8.2.9. Boehringer Ingelheim
8.2.10. Zoetis, Inc.
8.2.11. Pacific GeneTech
8.2.12. Avivagen Inc.
8.2.13. Hester Biosciences Limited
8.2.14. Venkys India
8.2.15. Calier
8.2.16. KM Biologics
8.2.17. Others
Poultry Pharmaceuticals Market By product type -
Poultry Pharmaceuticals Market By Animal Type -
Poultry Pharmaceuticals Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
